Completed PHASE4 INTERVENTIONAL 3-arm NCT03265223

Ropivacaine Use Intraincisionally Versus Intraperitoneally for Post-Laparoscopic Cholecystectomy Pain

Randomized Controlled Study of Intraincisional Infiltration Versus Intraperitoneal Instillation of Standardized Dose of Ropivacaine 0.2% in Post-laparoscopic Cholecystectomy Pain

Sponsor: Jawaharlal Nehru Medical College

Conditions Laparoscopic Cholecystectomy Pain Ropivacaine

Interventions 0.2% ropivacaine

Updated 5 times since 2017 Last updated: Aug 29, 2017 Started: Apr 1, 2014 Primary completion: Mar 31, 2017 Completion: Aug 15, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03265223, this PHASE4 trial focuses on Laparoscopic Cholecystectomy and Pain and remains completed. Sponsored by Jawaharlal Nehru Medical College, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Sep 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jawaharlal Nehru Medical College

Data source: Jawaharlal Nehru Medical College

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.